Your browser is no longer supported. Please, upgrade your browser.
Settings
JNJ Johnson & Johnson daily Stock Chart
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E26.41 EPS (ttm)5.55 Insider Own0.07% Shs Outstand2.69B Perf Week0.20%
Market Cap394.21B Forward P/E16.99 EPS next Y8.62 Insider Trans-22.52% Shs Float2.68B Perf Month0.83%
Income15.14B PEG3.40 EPS next Q1.95 Inst Own68.60% Short Float0.60% Perf Quarter5.77%
Sales81.38B P/S4.84 EPS this Y-8.50% Inst Trans0.56% Short Ratio2.22 Perf Half Y19.55%
Book/sh24.09 P/B6.08 EPS next Y5.63% ROA1.00% Target Price148.11 Perf Year4.20%
Cash/sh7.20 P/C20.36 EPS next 5Y7.77% ROE2.50% 52W Range118.62 - 148.99 Perf YTD4.85%
Dividend3.60 P/FCF43.17 EPS past 5Y7.10% ROI15.70% 52W High-1.67% Beta0.59
Dividend %2.46% Quick Ratio1.40 Sales past 5Y2.60% Gross Margin66.50% 52W Low23.50% ATR2.65
Employees134000 Current Ratio1.70 Sales Q/Q3.60% Oper. Margin21.40% RSI (14)61.14 Volatility2.22% 1.77%
OptionableYes Debt/Eq0.48 EPS Q/Q4.90% Profit Margin1.90% Rel Volume1.13 Prev Close145.26
ShortableYes LT Debt/Eq0.46 EarningsJan 15 BMO Payout526.10% Avg Volume7.32M Price146.50
Recom2.30 SMA200.99% SMA503.54% SMA20010.91% Volume8,272,825 Change0.85%
Jul-12-18Upgrade Goldman Sell → Neutral
Jun-27-18Initiated Bernstein Mkt Perform $129
Apr-23-18Reiterated Citigroup Neutral $146 → $134
Apr-18-18Reiterated Stifel Hold $145 → $135
Jan-24-18Reiterated Stifel Hold $142 → $145
Jan-12-18Reiterated Wells Fargo Outperform $155 → $160
Jan-02-18Downgrade JP Morgan Overweight → Neutral
Oct-18-17Reiterated Stifel Hold $140 → $142
Oct-18-17Reiterated RBC Capital Mkts Outperform $144 → $147
Oct-18-17Reiterated Leerink Partners Outperform $150 → $165
Oct-16-17Reiterated Jefferies Buy $157 → $160
Oct-11-17Upgrade Jefferies Hold → Buy
Oct-09-17Upgrade Wells Fargo Market Perform → Outperform
Sep-25-17Initiated Citigroup Neutral $140
Sep-20-17Downgrade Goldman Neutral → Sell $125 → $130
Jul-21-17Downgrade BTIG Research Neutral → Sell $110
Jul-21-17Downgrade Alembic Global Advisors Neutral → Underweight
Jul-20-17Resumed Credit Suisse Outperform $148
Jul-05-17Reiterated Morgan Stanley Overweight $135 → $140
May-18-17Reiterated Stifel Hold $124 → $128
Dec-11-18 06:11PM  Cramer: Pick individual stocks with long-term growth stories in this 'treacherous' market CNBC
04:15PM  Markets Right Now: Stock market ends mixed after a bumpy day Associated Press
03:01PM  Today's Stock Market: Dow Jones Volatile After Trump Spars With Democratic Leaders Investor's Business Daily
02:48PM  12 Stocks You Should Never Sell Kiplinger
11:56AM  Why Is Shopify Stock Holding Up While Others Cant Handle The Turmoil? InvestorPlace
10:55AM  Will Wayfair Stock Remain a Safety Play During Market Turbulence? InvestorPlace
09:51AM  Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800 Zacks
07:37AM  Pennovation Center-based biotech startup raises $13M American City Business Journals
Dec-10-18 03:20PM  19 Best Stocks to Buy for 2019 Kiplinger
10:12AM  The Zacks Analyst Blog Highlights: Apple, DowDuPont, Exxon Mobil, Johnson & Johnson and Verizon Communications Zacks
10:11AM  PFE Stock Has Broken Its Slump and Could Challenge Former Highs InvestorPlace
07:00AM  Today's Research Reports on Trending Tickers: Johnson & Johnson and Bristol-Myers Squibb ACCESSWIRE
Dec-09-18 08:59PM  Is Johnson & Johnson (JNJ) A Good Stock According To Hedge Funds? Insider Monkey
04:46PM  Here's Why BeiGene Stock Rose 21.7% in November Motley Fool
Dec-07-18 01:28AM  PRESS DIGEST-New York Times business news - Dec 7 Reuters
Dec-06-18 05:45PM  Johnson & Johnson (JNJ) Stock Moves -0.08%: What You Should Know Zacks
05:19PM  J&J unit to pay $360 million to U.S. to resolve charity kickback probe Reuters
05:11PM  Peninsula drug maker to pay $360M to settle Justice Department claims American City Business Journals
03:30PM  7 Dividend Titans Trading Like Growth Stocks InvestorPlace
01:34PM  Houston cancer pharma co. begins Phase I trials after $6M Series B American City Business Journals
01:05PM  Drug company Actelion to pay $360M in kickback probe Associated Press
12:23PM  J&J unit to pay $360 million to U.S. to resolve charity kickback probe Reuters
11:42AM  Can You Hide in Johnson and Johnson Stock Amid the Turmoil? InvestorPlace
10:40AM  AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study Zacks
12:15AM  [$$] Actelion Pharmaceuticals agrees to pay $360m in DoJ settlement Financial Times
Dec-05-18 03:53PM  Johnson & Johnson: An Excellent Business Selling at a Rational Price GuruFocus.com
09:38AM  J&J's Blood Cancer Drugs Succeed in Label Expansion Studies Zacks
09:14AM  Mylan Expands Recall of Valsartan to All Unexpired Lots Zacks
08:17AM  Can Celgene and bluebird bio Survive a Two-Pronged Attack? Motley Fool
Dec-04-18 04:58PM  J&J Strikes Deal with argenx to Co-Develop Cancer Antibody Zacks
04:18PM  P&G, Johnson & Johnson, Verizon Hold Strongest on Ugly Day for Dow Jones TheStreet.com
03:38PM  Better Buy: Intuitive Surgical vs. Johnson & Johnson Motley Fool
01:00PM  10 Defensive Stocks to Protect Your Portfolio in 2019 InvestorPlace
12:13PM  Johnson & Johnson CEO: Fix the Drug Pricing Process, But Not Too Much Meredith Videos
10:37AM  JNJ-AbbVie cancer drug Imbruvica succeeds in late-stage trial Reuters
10:30AM  J&J's multiple myeloma drug reduces risk of death in late-stage study Reuters
07:59AM  The Daily Biotech Pulse: ASH Presentations Take The Spotlight, Eiger Gets A New CFO Benzinga
07:19AM  Should You Be Worried About the Return of Big Pharma Deals? Motley Fool
12:20AM  Amgen antibody shows promise in myeloma trial, gets FDA fast track Reuters
Dec-03-18 07:01PM  Jim Cramer: Don't Throw Away These Stocks TheStreet.com
06:59PM  Cramer Remix: These recession-proof stocks are worth buying on a pullback CNBC
04:09AM  Dutch firm argenx, J&J affiliate to collaborate on cancer therapy Reuters
Dec-02-18 10:02PM  J&J to Build Blood-Cancer Push With Controversial China Biotech Bloomberg
10:31AM  [$$] Tech Companies Aren't the Only Ones Competing for Tech Workers The Wall Street Journal
09:35AM  [$$] Tech Companies Aren't the Only Ones Competing for Tech Workers The Wall Street Journal
Dec-01-18 07:03AM  Top Biotech Stocks to Watch at ASH 2018 Motley Fool
Nov-30-18 09:56AM  Key Pharma Players With HIV Focus Ahead of World Aids Day Zacks
09:05AM  [$$] Best-Run U.S. Companies of 2018---and How They Got That Way The Wall Street Journal
08:56AM  'Shark Tank' star Kevin OLeary reveals the type of stocks that should outperform in 2019 Yahoo Finance
07:20AM  Report: Developing Opportunities within Unifirst, Royal Caribbean Cruises, Albemarle, Tableau Software, Huami, and Johnson & Johnson Future Expectations, Projections Moving into 2018 GlobeNewswire
Nov-29-18 05:45PM  Johnson & Johnson (JNJ) Dips More Than Broader Markets: What You Should Know Zacks
04:47PM  Theravance Pipeline Strong, Plans Yupelri Launch by Year End Zacks
08:10AM  4 Big Pharma Stocks to Add to Your Portfolio in December Zacks
07:57AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Thermo Fisher, Goldman Sachs, Oracle and Accenture Zacks
Nov-28-18 07:20PM  [$$] New Parents Complain Amazon Baby-Registry Ads Are Deceptive The Wall Street Journal
02:15PM  Campbell Soup aims at former Pinnacle Foods chief to take CEO job American City Business Journals
10:20AM  Theravance's Respiratory Disease JAK Inhibitor Enters Phase I Zacks
10:07AM  [$$] New Parents Complain Amazon Ads Are Deceptive The Wall Street Journal
06:51AM  Time magazine names Tampa Bay-based invention among the best in 2018 American City Business Journals
Nov-27-18 04:35PM  Why Celgene's Blockbuster Cancer Drug Looks Safe For Now Investor's Business Daily
12:25PM  Novartis's Alcon sees myopia epidemic driving sales growth Reuters
10:34AM  3 Reasons Why Glaxo (GSK) Stock is Up This Year So Far Zacks
09:40AM  Glaxo (GSK) and J&J's HIV Drug Juluca Gets Approval in Japan Zacks
07:44AM  The Zacks Analyst Blog Highlights: Boeing, Microsoft, Johnson & Johnson, Chevron and Pfizer Zacks
Nov-26-18 06:35PM  Spinal-cord stimulators help some patients, injure others Associated Press
05:37PM  AMAG's Label Expansion of Lead Products Raises Share Price Zacks
09:33AM  Glaxo Inks Marketing Deal for Anaemia Candidate in Japan Zacks
09:23AM  The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca Zacks
08:00AM  Johnson & Johnson to Participate in the BMO Prescriptions for Success Healthcare Conference PR Newswire
02:38AM  [$$] Microsoft: Wall Streets most resilient mega-cap? Financial Times
Nov-25-18 10:00AM  Stock Market Power Rankings: Save Us, Amazon Motley Fool
Nov-23-18 02:05PM  Bayer Hurts from Generic Competition & Pipeline Setbacks Zacks
08:58AM  Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs Zacks
08:10AM  Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod Zacks
07:00AM  Today's Research Reports on Trending Tickers: Altimmune and Johnson & Johnson ACCESSWIRE
Nov-22-18 09:16AM  Pfizer's FDA Nod for Cancer Drug is Four in a Row in 90 Days Zacks
09:10AM  New Trends in Healthcare Push Stocks Higher: 5 Picks Zacks
08:31AM  J&J Loses Appeal to Halt Generic Zytiga Launch, Stock Down Zacks
Nov-21-18 04:27PM  Stock Market Rally Dampened As Dow Gives Up 200-Point Gain Investor's Business Daily
03:10PM  U.S. appeals court declines J&J bid to stop generic Zytiga sales Reuters
03:01PM  5 Top Stock Trades to Mull Over Thanksgiving InvestorPlace
02:05PM  J&J Falls After Failing to Block Generic Zytiga Cancer Drug Bloomberg
01:19PM  Johnson & Johnson's stock drops to pace Dow decliners after appeals court ruling on Zytiga disappoints MarketWatch
11:15AM  Theravance JAK Inhibitor Enters Phase II for Crohn's Disease Zacks
10:04AM  Mylan Recalls Valsartan Lots, Gets FDA Warning for Facility Zacks
09:36AM  Shire-Takeda Deal Gets Phase I Conditional European Approval Zacks
08:16AM  Can Deal Interest Help Tesaro Recover? Motley Fool
07:05AM  Today's Research Reports on Trending Tickers: Johnson & Johnson and Merck & Co. ACCESSWIRE
05:00AM  Capitalism Is Working in the U.S. Bloomberg
Nov-20-18 03:52PM  Glaxo Seeks Label Expansion of Nucala in Pediatric Patients Zacks
12:21PM  Here's What's Actually Working as the Market Sells Off: Charts TheStreet.com
11:41AM  5 Dow Stocks to Sell (And 2 to Buy) Kiplinger
10:57AM  5 Companies Hit 52-Week Highs GuruFocus.com
08:29AM  The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings Benzinga
Nov-19-18 05:45PM  Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know Zacks
05:15PM  Nasdaq Slides More Than 3% As These Dow Blue Chips Buck The Broad Sell-Off Investor's Business Daily
04:41PM  Bulls Stampeded by Bears as FAANG Stocks Get Trampled TheStreet.com
01:12PM  Pfizer, Other Pharma Stocks Should Continue to Do Well Amid Market Volatility TheStreet.com
12:32PM  Pfizer's Oncology Offerings Present Opportunity for Long-Term Stock Growth TheStreet.com
08:57AM  J&J Gets Positive CHMP Opinion for Prostate Cancer Treatment Zacks
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. Its Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, RoC, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand. This segment also provides women's health products, such as sanitary pads under the STAYFREE and CAREFREE brands, and tampons under the o.b. brand; wound care products comprising adhesive bandages under the BAND-AID brand and first aid products under the NEOSPORIN brand. The company's Pharmaceutical segment offers various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, cardiovascular and metabolic, and pulmonary hypertension diseases. Its Medical Devices segment provides orthopedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products that include blood glucose monitoring; and vision care products, such as disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery. The company markets its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fasolo PeterExec VP, Chief HR OfficerDec 04Option Exercise96.7341,5634,020,237119,890Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 04Sale146.6841,5636,096,55278,327Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Option Exercise94.12125,13211,777,919203,459Dec 06 05:27 PM
Fasolo PeterExec VP, Chief HR OfficerDec 03Sale146.32125,13218,308,68978,327Dec 06 05:27 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Option Exercise58.3330,9431,804,90570,817Nov 27 06:56 PM
Sneed Michael EEVP, Global Corp Aff & COONov 23Sale142.4630,9434,407,98539,874Nov 27 06:56 PM
Gorsky AlexChairman, CEONov 16Option Exercise62.39264,46516,500,026601,024Nov 16 07:44 PM
Gorsky AlexChairman, CEONov 16Sale145.96264,46538,600,968336,559Nov 16 07:44 PM
Kapusta Ronald AController, CAONov 08Sale145.158,4411,225,20017,284Nov 09 05:22 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Option Exercise62.9440,0002,517,526133,555Nov 09 05:20 PM
Duato JoaquinVice Chair, Exec CommitteeNov 07Sale144.3640,0005,774,48093,555Nov 09 05:20 PM
Kapusta Ronald AController, CAOSep 07Sale137.187,8991,083,60725,725Sep 11 03:53 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Option Exercise58.3329,0001,691,57059,124Aug 28 04:03 PM
Sneed Michael EEVP, Global Corp Aff & COOAug 27Sale134.8029,0003,909,08430,124Aug 28 04:03 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Option Exercise90.44155,34214,049,130357,906Feb 20 07:46 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 15Sale129.86155,34220,172,401202,564Feb 20 07:46 PM
Caruso Dominic JExec VP, Finance; CFOFeb 09Option Exercise0.0010,6010154,703Feb 13 06:54 PM
Duato JoaquinExec VP, WW Chair, PharmaFeb 09Option Exercise0.009,812078,348Feb 13 06:54 PM
Fasolo PeterExec VP, Chief HR OfficerFeb 09Option Exercise0.005,830069,992Feb 13 06:54 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0033,1650285,990Feb 13 06:54 PM
PETERSON SANDRA EExec VP, Group WW ChairmanFeb 09Option Exercise0.0011,445070,205Feb 13 06:54 PM
Stoffels PaulusExec VP, Chief Scientific OffFeb 09Option Exercise0.0013,2520181,655Feb 13 06:55 PM
Ullmann Michael HExec VP, General CounselFeb 09Option Exercise0.005,9530115,257Feb 13 06:55 PM
Kapusta Ronald AController, CAOFeb 09Option Exercise0.002,702032,666Feb 13 06:55 PM
Mesquita Jorge S.Exec VP, WW Chair, ConsumerFeb 02Option Exercise0.0032,688032,688Feb 06 04:21 PM